1. Home
  2. ODTX vs MBC Comparison

ODTX vs MBC Comparison

Compare ODTX & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo MasterBrand Inc.

MBC

MasterBrand Inc.

N/A

Current Price

$5.95

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ODTX
MBC
Founded
2021
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
ODTX
MBC
Price
$16.85
$5.95
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
★ $34.67
$7.87
AVG Volume (30 Days)
291.0K
★ 2.5M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $2,734,700,000.00
Revenue This Year
N/A
$25.97
Revenue Next Year
N/A
$15.44
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.27
52 Week Low
$15.10
$5.81
52 Week High
$29.05
$13.96

Technical Indicators

Market Signals
Indicator
ODTX
MBC
Relative Strength Index (RSI) 36.09 38.53
Support Level $15.73 N/A
Resistance Level $19.60 $7.46
Average True Range (ATR) 1.69 0.51
MACD -0.19 -0.09
Stochastic Oscillator 6.10 7.65

Price Performance

Historical Comparison
ODTX
MBC

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.

Share on Social Networks: